FDA 483 - Versiti Indiana Inc - May 07, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Versiti Indiana Inc, a blood bank in Indianapolis, revealed significant deficiencies in equipment maintenance, labeling, record-keeping, and adherence to standard operating procedures for HCT/Ps and blood products. Issues included unmaintained cryogenic freezers, improperly labeled tissues, unrecorded storage temperatures, and missing or incomplete documentation for processing and distribution steps. These observations indicate a lack of control over critical processes impacting product quality and traceability.
ID · 4b39e8da-04cc-4902-9542-1a53ca0a7a74